Publications by authors named "Jillian Howlin"

Claim this Profile
C
CITED1 as a marker of favourable outcome in anti-endocrine treated, estrogen-receptor positive, lymph-node negative breast cancer.
Malin Dahlgren, Barbara Lettiero, Hina Dalal, Kira Mårtensson, Alexander Gaber, Jillian Howlin

BMC Res Notes· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pubertal Mammary Gland Development: Elucidation of In Vivo Morphogenesis Using Murine Models.
Jean McBryan, Jillian Howlin

Methods Mol Biol· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serial monitoring of circulating tumor DNA in patients with primary breast cancer for detection of occult metastatic disease.
Eleonor Olsson, Christof Winter, Anthony George, Yilun Chen, Jillian Howlin

EMBO Mol Med· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genome-Wide DNA Methylation Analysis in Melanoma Reveals the Importance of CpG Methylation in MITF Regulation.
Martin Lauss, Rizwan Haq, Helena Cirenajwis, Bengt Phung, Katja Harbst, Jillian Howlin

J Invest Dermatol· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular stratification of metastatic melanoma using gene expression profiling: Prediction of survival outcome and benefit from molecular targeted therapy.
Helena Cirenajwis, Henrik Ekedahl, Martin Lauss, Katja Harbst, Ana Carneiro, Jillian Howlin

Oncotarget· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Loss of CITED1, an MITF regulator, drives a phenotype switch in vitro and can predict clinical outcome in primary melanoma tumours.
Jillian Howlin, Helena Cirenajwis, Barbara Lettiero, Johan Staaf, Martin Lauss

PeerJ· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Primary melanoma tumors from CDKN2A mutation carriers do not belong to a distinct molecular subclass.
Johan Staaf, Katja Harbst, Martin Lauss, Markus Ringnér, Anna Måsbäck, Jillian Howlin

J Invest Dermatol· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular and genetic diversity in the metastatic process of melanoma.
Katja Harbst, Martin Lauss, Helena Cirenajwis, Christof Winter, Jillian Howlin

J Pathol· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Global H3K27 trimethylation and EZH2 abundance in breast tumor subtypes.
Karolina Holm, Dorthe Grabau, Kristina Lövgren, Steina Aradottir, Sofia Gruvberger-Saal, Jillian Howlin

Mol Oncol· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Retracted manuscript: The WNT-5a derived peptide, Foxy-5, possesses dual properties that impair progression of ERα negative breast cancer.
Tommy Andersson, Caroline E Ford, Elin J Ekström, Jillian Howlin

Cell Cycle· April 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A t-butyloxycarbonyl-modified Wnt5a-derived hexapeptide functions as a potent antagonist of Wnt5a-dependent melanoma cell invasion.
Veronika Jenei, Victoria Sherwood, Jillian Howlin, Rickard Linnskog, Annette Säfholm

Proc Natl Acad Sci U S A· November 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Wnt-5a-induced phosphorylation of DARPP-32 inhibits breast cancer cell migration in a CREB-dependent manner.
Christian Hansen, Jillian Howlin, Anders Tengholm, Oleg Dyachok, Wolfgang F Vogel

J Biol Chem· October 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The WNT-5a derived peptide, Foxy-5, possesses dual properties that impair progression of ERalpha negative breast cancer.
Caroline E Ford, Elin J Ekström, Jillian Howlin, Tommy Andersson

Cell Cycle· June 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
IHG-1 amplifies TGF-beta1 signaling and is increased in renal fibrosis.
Madeline Murphy, Neil G Docherty, Brenda Griffin, Jillian Howlin, Emmett McArdle

J Am Soc Nephrol· September 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TNK2 preserves epidermal growth factor receptor expression on the cell surface and enhances migration and invasion of human breast cancer cells.
Jillian Howlin, Jeanette Rosenkvist, Tommy Andersson

Breast Cancer Res· July 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Amphiregulin: role in mammary gland development and breast cancer.
Jean McBryan, Jillian Howlin, Silvia Napoletano, Finian Martin

J Mammary Gland Biol Neoplasia· June 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pubertal mammary gland development: insights from mouse models.
Jillian Howlin, Jean McBryan, Finian Martin

J Mammary Gland Biol Neoplasia· October 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of Naf1/ABIN-1 among TNF-alpha-induced expressed genes in human synoviocytes using oligonucleotide microarrays.
Joanne Gallagher, Jillian Howlin, Conor McCarthy, Evelyn P Murphy, Barry Bresnihan

FEBS Lett· September 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis